文献速递关节外科

单次收肌管阻滞后股四头肌无力:1083例初次全膝关节置换术的多变量分析

Quadriceps Weakness After Single-Shot Adductor Canal Block: A Multivariate Analysis of 1,083 Primary Total Knee Arthroplasties.
PubMed 文献 · J Bone Joint Surg Am · 2021-01-01

该研究回顾性分析了1083例接受收肌管阻滞(ACB)的初次全膝关节置换术(TKA),股四头肌无力的患病率为9%。按体重指数(BMI)单位计算,ACB麻醉药剂量增加使股四头肌无力概率增加5.0倍(95%CI 1.9-13.3,p=0.001)。作者认为ACB中维持镇痛同时最小化股四头肌无力的最佳局麻药容量尚未确定。

要点

  • 单次ACB后临床相关股四头肌无力患病率为9%。
  • 按BMI单位计算,ACB麻醉药剂量增加使股四头肌无力概率增加5.0倍(95%CI 1.9-13.3,p=0.001)。
  • 股四头肌无力概率最高(52.9%)见于接受最高单位BMI麻醉药剂量并使用肾上腺素延长剂但未使用皮质类固醇延长剂的女性。

核心结论

  • ACB中维持镇痛同时最小化股四头肌无力的最佳局麻药容量尚未确定。
  • 股四头肌无力与按BMI单位计算ACB麻醉药剂量增加相关,提示选择注射剂和注射容量时应考虑超越传统结构管道填充参数(即填充收肌管远端而不扩散至股三角)的因素。

研究设计与样本

  • 回顾性审查1083例在学术髋膝关节中心接受ACB的连续初次全膝关节置换术。
  • 在初始物理治疗评估时使用标准化评级系统量化股四头肌无力,并分析23个潜在协变量。

主要发现

  • 股四头肌无力患病率为9%。
  • 按BMI单位计算,ACB麻醉药剂量增加使股四头肌无力概率增加5.0倍(95%CI 1.9-13.3,p=0.001)。
  • 股四头肌无力概率最高(52.9%)见于接受最高单位BMI麻醉药剂量并使用肾上腺素延长剂但未使用皮质类固醇延长剂的女性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adductor canal blocks (ACBs) are commonly employed in multimodal pain control for total knee arthroplasty (TKA) and minimize motor blockade compared with femoral nerve blocks. Quadriceps weakness may be associated with ACBs. The purpose of this study was to quantify the prevalence of clinically relevant quadriceps weakness after a single-shot ACB and to identify the factors that are associated with its diagnosis. METHODS: The study group consisted of 1,083 retrospectively reviewed consecutive TKAs that were performed with ACBs at an academic hip and knee center. Quadriceps weakness was quantified with a standardized rating system during the initial physical therapy evaluation, and 23 potential covariates were analyzed. RESULTS: The prevalence of quadriceps weakness was 9%. Increasing the dose of the ACB anesthetic per unit of body mass index (BMI) increased the probability of quadriceps weakness by 5.0 times (95% confidence interval [CI], 1.9 to 13.3; p = 0.001). The highest probability of quadriceps weakness (52.9%) was associated with women who received the highest anesthetic dose per unit of BMI and an epinephrine extender but no corticosteroid extender. CONCLUSIONS: The optimal volume of local anesthetic in ACBs to maintain pain control while minimizing quadriceps weakness has not yet been defined. Our observation that quadriceps weakness was associated with increasing doses of ACB anesthetic per unit of BMI suggests that more than traditional structural canal-fill parameters (i.e., filling the distal aspect of the adductor canal without spreading to the femoral triangle) should be considered when choosing injectates and injectate volumes for ACBs. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Yee EJ, Gapinski ZA, Ziemba-Davis M, et al. Quadriceps Weakness After Single-Shot Adductor Canal Block: A Multivariate Analysis of 1,083 Primary Total Knee Arthroplasties. J Bone Joint Surg Am. 2021. PMID: 33079899. doi:10.2106/JBJS.19.01425

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。